Moxifloxacino Kern Pharma

Moxifloxacin, the active ingredient in Moxifloxacino Kern Pharma, is a fluoroquinolone antibiotic presented as an oral tablet for systemic, oral use. It treats a range of bacterial infections, including respiratory and skin infections, in adult patients when prescribed by a qualified healthcare professional. The product complies with European Union quality standards and is intended for prescription‑only distribution. GNH USA supplies Moxifloxacino Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support.

Moxifloxacin is indicated for bacterial infections affecting the respiratory tract and skin, where it targets susceptible organisms. Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves pulmonary function. Acute bacterial sinusitis: reduces sinus inflammation and clears infection. Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. Skin and skin structure infections: eliminates bacterial load and promotes wound healing.

Moxifloxacin may cause adverse reactions ranging from mild to severe. Common Side Effects: - Nausea: mild stomach upset that may occur after dosing. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching. Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe allergic reaction: anaphylaxis with swelling, breathing difficulty, or hives. - Clostridioides difficile colitis: severe diarrhea with possible fever and abdominal pain.

When prescribing moxifloxacin, several safety considerations are recommended. Renal impairment: assess kidney function and adjust therapy if necessary. History of tendon disorders: avoid use due to risk of tendon rupture. QT prolongation risk: monitor ECG in patients with cardiac disease. Pregnancy and lactation: use only when benefits outweigh risks. Drug interactions: review concomitant medications for potential interactions. Store at room temperature: keep in the original pack, protect from moisture and light.

Moxifloxacin can interact with other medicines, requiring careful management. Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce oral absorption of moxifloxacin. - Ciprofloxacin or other fluoroquinolones: additive toxicity and resistance risk. - Warfarin: increased anticoagulant effect leading to bleeding. Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system adverse effects. - Theophylline: plasma concentrations may rise, requiring dose adjustment. - Cyclosporine: increased levels may occur; monitor renal function.